Artenimol/Piperaquine/Primaquine Phosphate/Trimethoprim

双氢青蒿素/哌喹/磷酸伯氨喹/甲氧苄啶

Report date: 2022/02/21 15:10:33

Base Information

Drug NameArtenimol/Piperaquine/Primaquine Phosphate/Trimethoprim
Drug Alias NameCV-8CV8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitorsCytochrome P450 inhibitorsMyeloperoxidase inhibitors
TargetsDihydrofolate reductaseCytochrome P450Myeloperoxidase
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsMalaria, Falciparum
Approved Indications in ChinaN/A
Original Approved Country/TerritoryVietnam
Original Approved Date2000/01/01
Country/TerritoryVietnam
CombinationsYes ArtenimolPiperaquinePrimaquine Phosphate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsMalaria, Falciparum
Inactive IndicationsN/A

Other Information

ATC CodeP01B
Related LinksN/A